×
About 7,019 results

ALLMedicine™ Glucose Intolerance Center

Research & Reviews  3,481 results

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Gen...
https://doi.org/10.1007/s40265-020-01393-x
Drugs Cernea S, Dima L et. al.

Sep 15th, 2020 - Fasting hyperglycemia, impaired glucose tolerance, prediabetes, and diabetes are frequently present in patients treated with second-generation antipsychotics (SGAPs) for schizophrenia, bipolar disorder, and other severe mental illnesses. These dru...

Prevalence of metabolic disturbances among women with polycystic ovary syndrome in diff...
https://doi.org/10.1002/ijgo.13374
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics; Maffazioli GD, Lopes CP et. al.

Sep 15th, 2020 - This study aims to describe the prevalence of metabolic disturbances in a large cohort of women with PCOS the southeastern Brazil and to compare the findings with other cohorts of Brazilian PCOS women. A retrospective study analyzing clinical and ...

The sphingosine-1-phosphate receptor modulator, FTY720, prevents the incidence of diabe...
https://doi.org/10.1111/1440-1681.13405
Clinical and Experimental Pharmacology & Physiology; Kobayashi K, Sasase T et. al.

Sep 13th, 2020 - The sphingosin-1-phosphate (S1P) receptor modulator regulates lymphocyte trafficking, resulting in its depletion from circulation which ultimately cause immunosuppression. In this study, we investigated the preventive effect of fingolimod (FTY720)...

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2.
https://doi.org/10.1073/pnas.2007856117
Proceedings of the National Academy of Sciences of the United States of America; Aji G, Huang Y et. al.

Sep 12th, 2020 - Sphingolipid dysregulation is often associated with insulin resistance, while the enzymes controlling sphingolipid metabolism are emerging as therapeutic targets for improving insulin sensitivity. We report herein that sphingosine kinase 2 (SphK2)...

Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-indu...
https://doi.org/10.1016/j.metabol.2020.154352
Metabolism: Clinical and Experimental; Merino B, Fernández-Díaz CM et. al.

Sep 11th, 2020 - The insulin-degrading enzyme (IDE) is a metalloendopeptidase with a high affinity for insulin. Human genetic polymorphisms in Ide have been linked to increased risk for T2DM. In mice, hepatic Ide ablation causes glucose intolerance and insulin res...

see more →

Guidelines  1 results

Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recom...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830751
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]; Rickels MR, Bellin M et. al.

Jul 30th, 2013 - Diabetes and glucose intolerance are common complications of chronic pancreatitis, yet clinical guidance on their detection, classification, and management is lacking. A working group reviewed the medical problems, diagnostic methods, and treatmen...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  3,503 results

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Gen...
https://doi.org/10.1007/s40265-020-01393-x
Drugs Cernea S, Dima L et. al.

Sep 15th, 2020 - Fasting hyperglycemia, impaired glucose tolerance, prediabetes, and diabetes are frequently present in patients treated with second-generation antipsychotics (SGAPs) for schizophrenia, bipolar disorder, and other severe mental illnesses. These dru...

Prevalence of metabolic disturbances among women with polycystic ovary syndrome in diff...
https://doi.org/10.1002/ijgo.13374
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics; Maffazioli GD, Lopes CP et. al.

Sep 15th, 2020 - This study aims to describe the prevalence of metabolic disturbances in a large cohort of women with PCOS the southeastern Brazil and to compare the findings with other cohorts of Brazilian PCOS women. A retrospective study analyzing clinical and ...

The sphingosine-1-phosphate receptor modulator, FTY720, prevents the incidence of diabe...
https://doi.org/10.1111/1440-1681.13405
Clinical and Experimental Pharmacology & Physiology; Kobayashi K, Sasase T et. al.

Sep 13th, 2020 - The sphingosin-1-phosphate (S1P) receptor modulator regulates lymphocyte trafficking, resulting in its depletion from circulation which ultimately cause immunosuppression. In this study, we investigated the preventive effect of fingolimod (FTY720)...

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2.
https://doi.org/10.1073/pnas.2007856117
Proceedings of the National Academy of Sciences of the United States of America; Aji G, Huang Y et. al.

Sep 12th, 2020 - Sphingolipid dysregulation is often associated with insulin resistance, while the enzymes controlling sphingolipid metabolism are emerging as therapeutic targets for improving insulin sensitivity. We report herein that sphingosine kinase 2 (SphK2)...

Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-indu...
https://doi.org/10.1016/j.metabol.2020.154352
Metabolism: Clinical and Experimental; Merino B, Fernández-Díaz CM et. al.

Sep 11th, 2020 - The insulin-degrading enzyme (IDE) is a metalloendopeptidase with a high affinity for insulin. Human genetic polymorphisms in Ide have been linked to increased risk for T2DM. In mice, hepatic Ide ablation causes glucose intolerance and insulin res...

see more →

News  33 results

Weight gain between pregnancies tied to gestational diabetes
https://www.reuters.com/article/us-health-pregnancy-diabetes/weight-gain-between-pregnancies-tied-to-gestational-diabetes-idUSKBN1AH5C8

Aug 1st, 2017 - (Reuters Health) - Women who gain substantial amounts of weight after their first pregnancy may be more likely to develop gestational diabetes during their next pregnancy, a Norwegian study suggests. Gestational diabetes is a form of glucose intol...

Novel Biomarker May Pinpoint Glucose Intolerance
https://www.medpagetoday.com/obgyn/pregnancy/64844

Apr 27th, 2017 - Action Points Measurement of the biomarker plasma glycated CD59 (pGCD59) was a strong predictor of pregnancy-induced glucose intolerance. Note that in a secondary analysis of 852 participants, large for gestational age newborns were associated wit...

Study asks whether artificial sweeteners may drive diabetes
https://www.reuters.com/article/us-health-diet-sweeteners/study-asks-whether-artificial-sweeteners-may-drive-diabetes-idUSKBN0HC1WK20140917

Sep 17th, 2014 - LONDON, Sept 17 (Reuters) - Scientists studying the effects of artificial sweeteners in mice and humans say they have found that eating them may increase the risk of developing glucose intolerance, a risk factor for diabetes. A person receives a t...

Gestational diabetes may increase child’s risk of glucose intolerance
https://www.mdedge.com/diabeteshub/article/86952/diabetes/gestational-diabetes-may-increase-childs-risk-glucose-intolerance
Tara Haelle

Sep 4th, 2014 - Obese children may have a higher risk of developing type 2 diabetes if their mothers had gestational diabetes during pregnancy, according to a recent study. "The ever growing number of women with gestational diabetes (18%) suggests that the future.

Evolving nanotechnology reveals potential treatment advantages
https://www.mdedge.com/familymedicine/article/82555/dermatology/evolving-nanotechnology-reveals-potential-treatment
Internal Medicine News; Doug Brunk

May 22nd, 2014 - DENVER – As the nanotechnology field evolves, there are at least three reasons a clinician might prefer to use nanoparticles over conventional drugs, according to Dr. Jack L.

see more →